Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

HIV RT inhibitors available for licensing from NIH

Jan. 15, 1998

Progenics, Roche collaborate on next-generation anti-HIV agents

Jan. 15, 1998

Novartis discloses HIV protease inhibitors with excellent pharmacodynamic profile

Jan. 14, 1998

Novel AIDS therapy shows promise

Jan. 14, 1998

Ribozyme HIV gene therapy demonstrates potential in phase I/II

Jan. 13, 1998

Anti-HIV fusion inhibitor from Trimeris advances to phase II

Jan. 12, 1998

Japanese launch announced for HIV protease inhibitor

Jan. 12, 1998

New antiviral agents emerge from European research collaboration

Jan. 9, 1998

Second-generation CMV retinitis compound enters phase I/II

Jan. 9, 1998

New AIDS treatment candidates disclosed by Vertex

Jan. 8, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...